Logo image of AZTR

AZITRA INC (AZTR) Stock Fundamental Analysis

USA - NYSEARCA:AZTR - US05479L3024 - Common Stock

0.39 USD
-0.01 (-2.5%)
Last: 11/12/2025, 11:53:00 AM
Fundamental Rating

1

AZTR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 531 industry peers in the Biotechnology industry. AZTR may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, AZTR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AZTR has reported negative net income.
In the past year AZTR has reported a negative cash flow from operations.
In the past 5 years AZTR always reported negative net income.
AZTR had a negative operating cash flow in each of the past 5 years.
AZTR Yearly Net Income VS EBIT VS OCF VS FCFAZTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of AZTR (-226.68%) is worse than 91.90% of its industry peers.
AZTR has a Return On Equity of -402.31%. This is in the lower half of the industry: AZTR underperforms 75.33% of its industry peers.
Industry RankSector Rank
ROA -226.68%
ROE -402.31%
ROIC N/A
ROA(3y)-185.51%
ROA(5y)-136.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AZTR Yearly ROA, ROE, ROICAZTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 200 -200 400 -400

1.3 Margins

AZTR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AZTR Yearly Profit, Operating, Gross MarginsAZTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -50K -100K

More info and screens

2

2. Health

2.1 Basic Checks

AZTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
AZTR has more shares outstanding than it did 1 year ago.
The debt/assets ratio for AZTR has been reduced compared to a year ago.
AZTR Yearly Shares OutstandingAZTR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500K 1M 1.5M
AZTR Yearly Total Debt VS Total AssetsAZTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -31.05, we must say that AZTR is in the distress zone and has some risk of bankruptcy.
AZTR has a worse Altman-Z score (-31.05) than 89.08% of its industry peers.
AZTR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
AZTR's Debt to Equity ratio of 0.00 is in line compared to the rest of the industry. AZTR outperforms 50.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -31.05
ROIC/WACCN/A
WACC8.66%
AZTR Yearly LT Debt VS Equity VS FCFAZTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M 15M

2.3 Liquidity

A Current Ratio of 1.24 indicates that AZTR should not have too much problems paying its short term obligations.
AZTR has a worse Current ratio (1.24) than 85.69% of its industry peers.
A Quick Ratio of 1.24 indicates that AZTR should not have too much problems paying its short term obligations.
AZTR has a worse Quick ratio (1.24) than 84.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 1.24
AZTR Yearly Current Assets VS Current LiabilitesAZTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for AZTR have decreased strongly by -29.82% in the last year.
The Revenue for AZTR has decreased by -98.91% in the past year. This is quite bad
Measured over the past years, AZTR shows a very negative growth in Revenue. The Revenue has been decreasing by -59.15% on average per year.
EPS 1Y (TTM)-29.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.43%
Revenue 1Y (TTM)-98.91%
Revenue growth 3Y-59.15%
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

The Earnings Per Share is expected to grow by 19.91% on average over the next years. This is quite good.
AZTR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 195.38% yearly.
EPS Next Y73.12%
EPS Next 2Y35.9%
EPS Next 3Y19.91%
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y195.38%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AZTR Yearly Revenue VS EstimatesAZTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
AZTR Yearly EPS VS EstimatesAZTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -100 -200 -300

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AZTR. In the last year negative earnings were reported.
Also next year AZTR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AZTR Price Earnings VS Forward Price EarningsAZTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AZTR Per share dataAZTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

A more expensive valuation may be justified as AZTR's earnings are expected to grow with 19.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.9%
EPS Next 3Y19.91%

More info and screens

0

5. Dividend

5.1 Amount

AZTR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AZITRA INC

NYSEARCA:AZTR (11/12/2025, 11:53:00 AM)

0.39

-0.01 (-2.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)N/A N/A
Inst Owners1.71%
Inst Owner Change0%
Ins Owners0.14%
Ins Owner Change0%
Market Cap1.37M
Revenue(TTM)7.50K
Net Income(TTM)-8.97M
Analysts82.86
Price Target12.23 (3035.9%)
Short Float %2.13%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)379.6%
EPS NQ rev (1m)1.9%
EPS NQ rev (3m)-269.05%
EPS NY rev (1m)-7.62%
EPS NY rev (3m)-402.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 183.04
P/FCF N/A
P/OCF N/A
P/B 0.62
P/tB 0.7
EV/EBITDA N/A
EPS(TTM)-15.78
EYN/A
EPS(NY)-2.13
Fwd EYN/A
FCF(TTM)-3.12
FCFYN/A
OCF(TTM)-3.11
OCFYN/A
SpS0
BVpS0.63
TBVpS0.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -226.68%
ROE -402.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-185.51%
ROA(5y)-136.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.3%
Cap/Sales 269.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 1.24
Altman-Z -31.05
F-Score3
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)28.36%
Cap/Depr(5y)202.85%
Cap/Sales(3y)51.41%
Cap/Sales(5y)122.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.43%
EPS Next Y73.12%
EPS Next 2Y35.9%
EPS Next 3Y19.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-98.91%
Revenue growth 3Y-59.15%
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y195.38%
EBIT growth 1Y-47.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.32%
OCF growth 3YN/A
OCF growth 5YN/A

AZITRA INC / AZTR FAQ

What is the ChartMill fundamental rating of AZITRA INC (AZTR) stock?

ChartMill assigns a fundamental rating of 1 / 10 to AZTR.


Can you provide the valuation status for AZITRA INC?

ChartMill assigns a valuation rating of 0 / 10 to AZITRA INC (AZTR). This can be considered as Overvalued.


Can you provide the profitability details for AZITRA INC?

AZITRA INC (AZTR) has a profitability rating of 0 / 10.


What is the financial health of AZITRA INC (AZTR) stock?

The financial health rating of AZITRA INC (AZTR) is 2 / 10.